These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8217114)

  • 1. Histological grade, DNA ploidy and mean nuclear volume as prognostic factors in prostatic cancer.
    Nielsen K; Overgaard J; Bentzen SM; Bruun E
    APMIS; 1993 Aug; 101(8):614-20. PubMed ID: 8217114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy.
    Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG
    Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
    Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM
    Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of DNA ploidy in clinically localized prostate cancer treated with radiation therapy.
    Gauwitz MD; Pollack A; el-Naggar AK; Terry NH; von Eschenbach AC; Zagars GK
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):821-8. PubMed ID: 8138434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
    Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH
    Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry.
    Winkler HZ; Rainwater LM; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
    Mayo Clin Proc; 1988 Feb; 63(2):103-12. PubMed ID: 3339904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE; André S; Soares J
    J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy, S phase fraction and G2 fraction as prognostic determinants in prostatic adenocarcinoma.
    Eskelinen M; Lipponen P; Majapuro R; Syrjänen K; Nordling S
    Eur Urol; 1991; 20(1):62-6. PubMed ID: 1743234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of nuclear DNA content in prostatic carcinoma.
    Forsslund G; Esposti PL; Nilsson B; Zetterberg A
    Cancer; 1992 Mar; 69(6):1432-9. PubMed ID: 1540880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
    Vesalainen S; Nordling S; Lipponen P; Talja M; Syrjänen K
    Br J Cancer; 1994 Aug; 70(2):309-14. PubMed ID: 8054280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical usefulness of flow cytometric DNA analysis in prostatic cancer].
    Ishikawa A
    Hinyokika Kiyo; 1992 Jun; 38(6):665-70. PubMed ID: 1632320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cure.
    Borre M; Høyer M; Nerstrøm B; Overgaard J
    Prostate; 1998 Sep; 36(4):244-9. PubMed ID: 9719024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value of DNA ploidy in prostatic cancer].
    Martínez Jabaloyas JM; Ruiz Cerdá JL; Sanz Chinesta S; Jiménez A; Hernández M; Jiménez Cruz JF
    Actas Urol Esp; 2001 Apr; 25(4):283-90. PubMed ID: 11455830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
    Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
    Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological grading and DNA ploidy as prognostic markers in metastatic prostatic cancer.
    Jørgensen T; Yogesan K; Skjørten F; Berner A; Tveter KJ; Danielsen HE
    Br J Cancer; 1995 May; 71(5):1055-60. PubMed ID: 7734299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-ploidy as prognostic factor in prostatic carcinoma.
    Haugen OA; Mjølnerød O
    Int J Cancer; 1990 Feb; 45(2):224-8. PubMed ID: 2303288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxyribonucleic acid ploidy of core biopsies and metastatic lymph nodes of prostate cancer patients: impact on time to progression. The European Organization for Research and Treatment of Cancer Genitourinary Group.
    van den Ouden D; Tribukait B; Blom JH; Fossa SD; Kurth KH; ten Kate FJ; Heiden T; Wang N; Schroder FH
    J Urol; 1993 Aug; 150(2 Pt 1):400-6. PubMed ID: 8326563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.